Jack A. Khattar - 18 Mar 2022 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
President, CEO, Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
18 Mar 2022
Transactions value $
$0
Form type
4
Filing time
23 Mar 2022, 21:21:03 UTC
Previous filing
13 Jan 2023
Next filing
23 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Other +10,750 +1.74% 627,216 18 Mar 2022 Direct F1, F2
transaction SUPN Common Stock Other -10,750 -1.02% 1,047,700 18 Mar 2022 By the KBT Trust F1, F2
holding SUPN Common Stock 4,000 18 Mar 2022 By son F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was first notified of the completed transaction by the transfer agent on the filing date.
F2 The Reporting Person is filing this Form 4 to reflect the fact that 10,750 shares were transferred from the KBT Trust to the Reporting Person on March 18, 2022 without consideration and are now owned directly.
F3 The Reporting Person disclaims beneficial ownership of the shares held by his son, who shares the Reporting Person's household, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.